Womens College of pharmacy, Peth Vadgaon, Kolhapur, Maharashtra
Three-dimensional (3D) printing, also known as additive manufacturing, has emerged as a transformative technology in pharmaceutical sciences. It enables the fabrication of complex drug delivery systems with precise control over drug release profiles, dosage, and geometry. This technology has opened new avenues in personalized medicine, allowing customization of dosage forms according to patient-specific needs. Various 3D printing techniques such as fused deposition modeling (FDM), stereolithography (SLA), selective laser sintering (SLS), and inkjet printing have been explored for pharmaceutical applications. This review highlights the principles, techniques, materials, applications, advantages, limitations, and future prospects of 3D printing in drug design and formulation. The integration of 3D printing with pharmaceutical sciences is expected to revolutionize drug development and patient care.
The pharmaceutical sciences have undergone significant transformation over the past few decades, driven by advancements in drug discovery, formulation technologies, and patient-centered healthcare approaches [1,2]. Traditional pharmaceutical manufacturing methods, although well-established and widely used, often rely on mass production techniques that are not flexible enough to meet the growing demand for personalized therapies [2,3]. These conventional approaches typically produce standardized dosage forms with fixed drug strengths, which may not be suitable for all patients due to variations in age, weight, metabolism, genetic profile, and disease condition [3,4]. As a result, there is an increasing need for innovative technologies that can enable customization, improve therapeutic efficacy, and enhance patient compliance [4,5].
In this context, three-dimensional (3D) printing, also known as additive manufacturing, has emerged as a revolutionary technology with the potential to transform pharmaceutical development and manufacturing [1,5]. Unlike conventional subtractive manufacturing processes, 3D printing involves the layer-by-layer deposition of materials to create complex three-dimensional structures directly from digital designs [6]. This approach allows for precise control over the geometry, internal structure, and composition of dosage forms, making it possible to design drug delivery systems with tailored release profiles and individualized dosing [6,7].
The application of 3D printing in pharmaceutical sciences gained considerable attention following the approval of the first 3D-printed drug, Spritam® (levetiracetam), by the U.S. Food and Drug Administration (FDA) in 2015 [8,9]. This milestone demonstrated the feasibility of using 3D printing technology for large-scale pharmaceutical production and highlighted its potential to address unmet medical needs [8]. Spritam® utilizes ZipDose® technology to produce highly porous tablets, enabling rapid disintegration and improved bioavailability [9,10].
One of the most significant advantages of 3D printing in pharmaceutical sciences is its ability to facilitate personalized medicine [5,7]. Personalized medicine aims to tailor therapeutic interventions based on individual patient characteristics, thereby maximizing treatment efficacy while minimizing adverse effects [10]. With 3D printing, it is possible to fabricate dosage forms with specific drug combinations, doses, shapes, and release characteristics according to patient needs [7,11]. Additionally, the development of polypills helps reduce pill burden and improve patient adherence [11,12].
2. PRINCIPLE OF 3D PRINTING
The principle of three-dimensional (3D) printing, also referred to as additive manufacturing, is based on the fabrication of three-dimensional objects through controlled, layer-by-layer deposition of materials guided by a digital model [13,14]. In pharmaceutical sciences, this technique enables precise engineering of dosage forms with defined geometry, internal structure, and drug distribution, thereby influencing drug release behavior, bioavailability, and therapeutic efficacy [14,15]. Unlike conventional subtractive manufacturing methods, 3D printing minimizes material wastage and allows the fabrication of complex and patient-specific dosage forms [13,16].
2.1 Digital Design and Modeling
The process begins with the creation of a three-dimensional model using computer-aided design (CAD) software [16,17]. This digital model defines critical parameters such as size, shape, porosity, internal channels, and spatial distribution of active pharmaceutical ingredients (APIs) and excipients [17]. The design phase plays a crucial role in determining the final performance of the dosage form, especially in achieving controlled or modified drug release profiles [18].
2.2 File Conversion and Slicing
The CAD model is converted into a Standard Tessellation Language (STL) file, which represents the object’s surface geometry using a mesh of triangles [13]. The STL file is then processed using slicing software that divides the model into thin horizontal layers and generates machine-readable instructions (G-code) for the printer [14,18]. These instructions guide parameters such as printing speed, deposition pattern, and layer thickness [18].
2.3 Layer-by-Layer Deposition of Material
In this stage, the 3D printer constructs the dosage form by depositing or solidifying material layer by layer according to the sliced data [15,19]. The mechanism of deposition depends on the printing technique used, such as extrusion in fused deposition modeling (FDM), droplet deposition in inkjet printing, or photopolymerization in stereolithography (SLA) [19,20]. This process ensures precise placement of drug and excipients, enabling uniform or gradient drug distribution within the dosage form [20].
2.4 Solidification and Interlayer Bonding
After deposition, each layer undergoes solidification through processes such as cooling, solvent evaporation, or exposure to light or laser energy [21]. Proper interlayer bonding is essential to maintain the mechanical strength, structural integrity, and uniformity of the dosage form [21,22]. Poor bonding may lead to defects such as delamination or inconsistent drug release behavior [22].
2.5 Post-Processing Operations
Following printing, the dosage form may undergo post-processing steps such as drying, curing, sintering, or removal of residual solvents [14,23]. These processes improve the physicochemical stability, mechanical strength, and overall quality of the final product, ensuring its suitability for therapeutic use [23].
2.6 Control of Drug Release and Dosage Precision
One of the key advantages of 3D printing is its ability to control drug release kinetics and ensure dosage precision [15,24]. By adjusting parameters such as layer thickness, infill density, and material composition, it is possible to design dosage forms with immediate, sustained, or pulsatile drug release [24]. Precise dosing can also be achieved by controlling the amount of drug incorporated in each layer, making this technology highly suitable for personalized medicine [25].
2.7 Reproducibility and Process Optimization
Advanced 3D printing systems provide high reproducibility through automation and digital standardization [16,25]. Process parameters can be optimized to ensure batch-to-batch consistency, which is critical for pharmaceutical applications [25,26]. Integration with computational tools and Quality by Design (QbD) approaches further enhances process reliability and product quality [26].
3. TYPES OF 3D PRINTING TECHNIQUES IN PHARMACEUTICALS
Three-dimensional (3D) printing technologies used in pharmaceutical sciences vary based on the mechanism of material deposition, energy source, and type of formulation employed [27,28]. Each technique offers unique advantages and limitations, making them suitable for specific drug delivery applications [28,29]. The most commonly used techniques are described below.
Figure 1: Types of 3D Printing Techniques in Pharmaceutical Sciences
3.1 Fused Deposition Modeling (FDM)
Fused deposition modeling is one of the most widely used 3D printing techniques in pharmaceutical applications due to its simplicity, affordability, and adaptability (29,30). In this method, thermoplastic polymers such as polylactic acid (PLA) and polyvinyl alcohol (PVA) are heated above their melting or glass transition temperature and extruded through a nozzle to form layers (30).
The drug is typically incorporated into polymeric filaments using hot-melt extrusion prior to printing (31). FDM enables the fabrication of dosage forms with controlled geometry and drug release profiles. However, high processing temperatures may lead to degradation of thermolabile drugs, which limits its applicability for heat-sensitive compounds [31,32].
3.2 Stereolithography (SLA)
Stereolithography is a photopolymerization-based technique that uses ultraviolet (UV) or visible light to selectively cure liquid resin into solid layers [33]. It offers high resolution, excellent surface finish, and the ability to produce complex geometries [33,34].
In pharmaceutical applications, drugs can be incorporated into photosensitive resins to produce precise dosage forms. Despite its advantages, the presence of potentially toxic photoinitiators and the limited availability of biocompatible resins present challenges for its widespread use [34,35].
3.3 Selective Laser Sintering (SLS)
Selective laser sintering is a powder-based technique that uses a high-energy laser to fuse powdered materials such as polymers or drug-excipient mixtures [36]. This process does not require solvents, making it advantageous for certain formulations [36,37].
SLS allows the fabrication of porous structures, which are particularly useful for producing rapidly disintegrating tablets and enhancing drug dissolution [37]. However, high temperatures generated during laser sintering may compromise the stability of heat-sensitive drugs [38].
3.4 Inkjet Printing
Inkjet printing is a droplet-based technique in which small volumes of drug solution or suspension are deposited onto a substrate in a controlled manner [39]. It is highly suitable for low-dose and potent drugs due to its precision and accuracy [39,40].
Inkjet printing can be classified into continuous inkjet and drop-on-demand systems. This technique is widely used for fabricating orodispersible films and personalized dosage forms [40]. However, limitations include nozzle clogging, restricted viscosity range, and solvent compatibility issues [41].
3.5 Binder Jet Printing
Binder jet printing involves the selective deposition of a liquid binder onto a powder bed to bind particles layer by layer [42]. This method is particularly useful for producing highly porous structures, such as fast-dissolving tablets [42,43].
The first FDA-approved 3D printed drug, Spritam®, was developed using a binder jetting technique, demonstrating its industrial feasibility [43]. However, the printed products may exhibit low mechanical strength, requiring additional post-processing to improve stability [44].
4. Materials Used in 3D Printing
The selection of suitable materials is a critical factor in pharmaceutical 3D printing, as it directly influences printability, mechanical strength, drug stability, and release characteristics of the final dosage form [45,46]. Materials used in 3D printing include polymers, hydrogels, active pharmaceutical ingredients (APIs), excipients, solvents, and emerging functional materials [46,47].
Figure 2 : Materials Used in 3D Printing in Pharmaceutical Sciences
4.1 Polymers
Polymers are the primary structural components in most 3D printed pharmaceutical formulations and play a vital role in determining the physical and functional properties of dosage forms [47,48]. Thermoplastic polymers such as polylactic acid (PLA) and polyvinyl alcohol (PVA) are widely used in fused deposition modeling (FDM) due to their thermal processability and mechanical strength [48].
Hydrophilic polymers like hydroxypropyl methylcellulose (HPMC) and polyethylene oxide (PEO) are commonly used for controlled drug release, as they swell upon contact with aqueous fluids and regulate drug diffusion [49]. Additionally, pH-sensitive polymers such as Eudragit are utilized for site-specific drug delivery in the gastrointestinal tract [49,50].
The choice of polymer depends on its compatibility with the drug, thermal stability, viscosity, and degradation behavior, all of which affect the printability and performance of the dosage form [50].
4.2 Hydrogels
Hydrogels are three-dimensional cross-linked polymeric networks capable of absorbing large amounts of water or biological fluids [51]. They are widely used in semi-solid extrusion and bioprinting techniques due to their excellent biocompatibility and flexibility [51,52].
Common hydrogel materials include gelatin, alginate, and chitosan, which are particularly suitable for encapsulating sensitive drugs such as proteins and peptides [52]. Hydrogels enable diffusion-controlled drug release and can be engineered to respond to environmental stimuli such as pH and temperature, making them useful for smart drug delivery systems [53].
4.3 Active Pharmaceutical Ingredients (APIs)
Active pharmaceutical ingredients are responsible for the therapeutic effect of the dosage form and must be carefully selected for compatibility with the printing process [46,54]. Their physicochemical properties, such as solubility, melting point, and stability, significantly influence their suitability for different printing techniques [54].
For instance, APIs used in FDM must withstand high temperatures, whereas those used in inkjet printing should be soluble or uniformly dispersible in the printing medium [55]. Uniform distribution of APIs within the printed matrix is essential to ensure dose accuracy and reproducibility [55,56].
4.4 Excipients
Excipients play a supportive role in enhancing the physical and functional properties of 3D printed dosage forms [56,57]. Plasticizers such as polyethylene glycol (PEG) and glycerol are used to improve polymer flexibility and reduce processing temperature [57].
Fillers like lactose and microcrystalline cellulose provide structural integrity, while disintegrants such as sodium starch glycolate facilitate rapid tablet disintegration [58]. Surfactants and lubricants may also be added to improve drug dispersion and printing performance [58].
4.5 Solvents and Vehicles
Solvents are essential in techniques such as inkjet printing, binder jetting, and stereolithography, where they are used to dissolve or disperse APIs and excipients [59]. Common solvents include water, ethanol, and other pharmaceutically acceptable organic solvents [59,60].
The choice of solvent affects viscosity, surface tension, evaporation rate, and droplet formation, which ultimately influence printing accuracy and product quality [60]. Proper post-processing is required to remove residual solvents and ensure product safety [60,61].
4.6 Emerging and Functional Materials
Recent advancements in material science have led to the development of novel functional materials that enhance the capabilities of pharmaceutical 3D printing [62]. Stimuli-responsive polymers can alter their properties in response to environmental triggers such as pH, temperature, or enzymatic activity, enabling controlled and targeted drug delivery [62,63].
Biodegradable polymers such as polylactic-co-glycolic acid (PLGA) are widely used for sustained drug delivery applications due to their safe degradation profile [63]. Additionally, nanocomposites and nanoparticle-based systems are being explored to improve drug solubility and bioavailability [64].
Bio-inks containing living cells and biomolecules are also being developed for bioprinting applications in tissue engineering and regenerative medicine, expanding the scope of 3D printing beyond conventional drug delivery systems [64,65].
5. Applications of 3D Printing in Pharmaceutical Sciences (with citations)
Three-dimensional (3D) printing has emerged as a highly versatile and transformative technology in pharmaceutical sciences, offering innovative solutions in drug design, formulation, and delivery (66,67). Its ability to fabricate complex, patient-specific dosage forms has significantly expanded its applications in modern therapeutics [67,68].
5.1 Personalized Medicine
One of the most significant applications of 3D printing is in personalized medicine, where drug therapy is tailored according to individual patient characteristics such as age, weight, genetic profile, and disease condition [68,69]. This approach enables precise dose adjustment, reduces adverse drug reactions, and improves therapeutic efficacy [69].
3D printing allows the fabrication of customized dosage forms with specific drug release profiles, making it highly suitable for individualized treatment [70].
5.2 Complex Drug Delivery Systems
3D printing enables the development of complex drug delivery systems that are difficult to achieve using conventional manufacturing techniques [70,71]. These include multilayer tablets, core-shell structures, and geometrically modified dosage forms designed to provide controlled, sustained, or pulsatile drug release [71].
By modifying internal architecture and porosity, drug release kinetics can be precisely controlled, enhancing therapeutic outcomes [72].
5.3 Polypill Formulations
3D printing facilitates the development of polypills, which combine multiple drugs into a single dosage form [73]. This is particularly useful in the management of chronic diseases such as hypertension, diabetes, and cardiovascular disorders [73,74].
Each drug in a polypill can be incorporated into separate compartments with different release profiles, improving patient compliance and reducing pill burden [74].
5.4 Pediatric and Geriatric Drug Delivery
3D printing offers significant advantages in designing dosage forms for pediatric and geriatric populations [75]. Customized shapes, sizes, and flavors can be developed to enhance patient acceptability and adherence [75,76]. Additionally, precise dose adjustment is possible, which is critical for these populations due to variations in pharmacokinetics and drug sensitivity [76].
5.5 On-Demand Drug Manufacturing
3D printing enables on-demand production of drugs at hospitals, pharmacies, or remote locations [77]. This reduces the need for large-scale manufacturing, minimizes drug wastage, and ensures timely availability of medications [77,78].
It is especially beneficial in emergency situations and for rare diseases requiring individualized therapy [78].
5.6 Rapid Prototyping and Drug Development
The technology supports rapid prototyping of dosage forms during drug development [79]. Researchers can quickly design, modify, and test different formulations, thereby reducing development time and cost [79,80].
This accelerates innovation and optimization in pharmaceutical research [80].
5.7 Tissue Engineering and Regenerative Medicine
3D bioprinting is widely used for fabricating biological tissues and scaffolds for regenerative medicine applications [81]. These structures are used for drug testing, disease modeling, and development of advanced therapies [81,82].
This approach also reduces reliance on animal testing by enabling human tissue-based studies [82].
5.8 Implantable Drug Delivery Systems
3D printing enables the fabrication of implantable drug delivery devices that provide sustained and controlled drug release over extended periods [83]. These systems are particularly useful in chronic diseases such as cancer and neurological disorders [83,84].
5.9 Orodispersible and Fast-Dissolving Dosage Forms
Highly porous structures produced by 3D printing can dissolve rapidly in the oral cavity without the need for water [85]. These formulations are particularly beneficial for patients with swallowing difficulties, including pediatric and geriatric patients [85,86].
5.10 Drug Screening and Preclinical Testing
3D printed tissue models and organ-on-chip systems are increasingly used for drug screening and toxicity studies [87]. These models provide more accurate and reliable results compared to traditional methods [87,88], thereby improving the efficiency of preclinical research.
6. Role of 3D Printing in Personalized and Precision Medicine
Three-dimensional (3D) printing has emerged as a transformative technology in personalized and precision medicine, enabling the development of patient-specific dosage forms tailored to individual needs [89,90]. Conventional pharmaceutical manufacturing follows a “one-size-fits-all” approach, which often fails to address inter-individual variability in pharmacokinetics and pharmacodynamics [90,91]. In contrast, 3D printing allows the fabrication of customized drug products based on patient-specific parameters such as age, body weight, genetic profile, disease condition, and metabolic rate [91,92].
6.1 Concept of Personalized Medicine and Need for Dose Individualization
Personalized medicine involves designing therapeutic interventions according to the unique characteristics of individual patients [92]. This approach improves therapeutic efficacy while minimizing adverse drug reactions [93].
3D printing provides a flexible platform for producing small batches of customized dosage forms without altering the manufacturing setup [94]. Unlike conventional dosage forms, which are available in fixed strengths, 3D printed medicines allow precise dose adjustment, eliminating the need for tablet splitting and reducing dosing errors [94,95].
6.2 Individualized Dosage Design Based on Patient Characteristics
6.2.1 Dose Adjustment According to Body Weight and Age
Drug dosage often varies depending on patient age and body weight, particularly in pediatric and geriatric populations [95,96]. 3D printing enables the fabrication of dosage forms with varying drug concentrations, sizes, and geometries, allowing accurate dose customization [96].
6.2.2 Customization According to Disease Severity
Patients with different stages of disease may require different drug doses [97]. 3D printing allows the production of dosage forms with adjustable drug loading, ensuring appropriate therapy for mild, moderate, or severe conditions [97,98].
6.2.3 Chronotherapeutic Drug Delivery
Certain diseases exhibit circadian rhythms, requiring time-dependent drug release [98]. 3D printing enables the fabrication of dosage forms with programmed release profiles, such as immediate, delayed, or pulsatile release systems [99].
6.3 Application of Pharmacogenomics in 3D Printed Medicines
Pharmacogenomics studies the influence of genetic variations on drug response [100]. Genetic polymorphisms can affect drug metabolism, leading to variability in therapeutic outcomes [100,101].
3D printing offers the potential to integrate pharmacogenomic data into drug formulation, enabling the production of personalized medicines with optimized dosing and release characteristics [101,102]. This is particularly important for drugs with a narrow therapeutic index, where precise dosing is critical [102].
6.4 Development of Polypills Through 3D Printing
Polypharmacy is common in chronic diseases such as hypertension, diabetes, and cardiovascular disorders [103]. 3D printing facilitates the development of polypills containing multiple drugs with different release profiles in a single dosage form [103,104].
This approach reduces pill burden, improves patient compliance, and minimizes medication errors [104].
6.5 Application in Pediatric Medicine
Pediatric patients require flexible dosing, palatable formulations, and easy-to-administer dosage forms [105]. 3D printing enables the fabrication of child-friendly formulations with customized shapes, flavors, and doses [105,106].
Additionally, orodispersible tablets can be produced to improve ease of administration in children [106].
6.6 Application in Geriatric Patients
Geriatric patients often suffer from multiple chronic conditions and require long-term medication therapy [107]. 3D printing enables the production of low-dose formulations, polypills, and easy-to-swallow dosage forms, improving adherence and therapeutic outcomes [107,108].
6.7 Clinical Significance of Personalized 3D Printed Medicines
Personalized 3D printed medicines offer several clinical advantages, including improved therapeutic efficacy, reduced adverse drug reactions, and enhanced patient compliance [109].
Furthermore, the ability to produce customized medicines on-demand at healthcare facilities supports decentralized manufacturing and improves access to medications [110].
7. Integration of 3D Printing with Artificial Intelligence and Digital Health Technologies
The integration of three-dimensional (3D) printing with artificial intelligence (AI), machine learning (ML), and digital health technologies represents a significant advancement in pharmaceutical sciences, enabling the development of intelligent and personalized drug delivery systems [111,112]. While 3D printing provides the capability to fabricate customized dosage forms, AI enhances decision-making by analyzing complex datasets and optimizing formulation and manufacturing processes [112,113].
7.1 Artificial Intelligence in Pharmaceutical Formulation Design
Artificial intelligence refers to computational systems capable of performing tasks that require human intelligence, such as pattern recognition, prediction, and optimization [113]. In pharmaceutical formulation development, AI can analyze large datasets related to drug properties, polymer characteristics, and process parameters [114].
Traditional formulation development often relies on trial-and-error experimentation, which is time-consuming and costly [114]. AI-driven approaches can predict optimal formulation parameters, including polymer selection, drug–excipient compatibility, and printing conditions, thereby accelerating the development process [115].
7.2 Machine Learning for Prediction of Drug Release
Machine learning, a subset of AI, enables predictive modeling based on experimental data [116]. In 3D printed drug delivery systems, ML algorithms can predict drug release behavior based on variables such as geometry, porosity, polymer composition, and printing parameters [116,117].
For example, ML models can estimate how changes in tablet structure or composition affect dissolution profiles, enabling the design of dosage forms with precise therapeutic performance [117]. This reduces the need for extensive experimental trials and enhances formulation efficiency [118].
7.3 Digital Twin Technology
Digital twin technology involves the creation of a virtual replica of a physical system to simulate and predict its behavior [119]. In pharmaceutical 3D printing, digital twins can model dosage forms and predict critical attributes such as drug release, mechanical strength, and stability [119,120].
This approach allows researchers to test and optimize designs in a virtual environment before actual manufacturing, reducing material wastage and improving process efficiency [120].
7.4 Real-Time Monitoring and Smart Manufacturing
The integration of 3D printing with Industry 4.0 technologies enables smart manufacturing systems with real-time monitoring and control [121]. Sensors and imaging systems can continuously monitor parameters such as temperature, layer formation, and drug distribution during the printing process [121,122].
AI algorithms can analyze this data and automatically adjust printing parameters to ensure product quality and consistency [122]. This leads to improved reproducibility, reduced errors, and enhanced quality assurance in pharmaceutical manufacturing [123].
7.5 Internet of Medical Things (IoMT) and Connected Drug Delivery
The Internet of Medical Things (IoMT) refers to interconnected medical devices that collect and exchange patient data in real time [124]. Integration of IoMT with 3D printing enables the development of responsive and adaptive drug delivery systems [124,125].
For instance, wearable devices can monitor physiological parameters such as glucose levels or blood pressure, and this data can be used to adjust drug dosing through 3D printed formulations [125]. This enables dynamic and personalized treatment strategies [126].
7.6 AI-Driven On-Demand Drug Printing
AI-driven 3D printing systems have the potential to enable on-demand drug manufacturing at healthcare facilities or even at home [127]. These systems can analyze patient data, determine optimal drug dosage, and fabricate personalized medicines in real time [127,128].
Such advancements could significantly improve access to medicines, reduce healthcare costs, and enhance therapeutic outcomes [128].
7.7 Challenges in Integration of AI with 3D Printing
Despite its potential, the integration of AI with 3D printing faces several challenges [129]. These include the need for large datasets for model training, lack of standardization, data privacy concerns, and regulatory uncertainties [129,130].
Ensuring data security and establishing robust regulatory frameworks are essential for the safe and effective implementation of AI-assisted 3D printed pharmaceuticals [130].
8. Regulatory Considerations
The emergence of three-dimensional (3D) printing in pharmaceutical sciences has introduced new regulatory challenges related to quality, safety, efficacy, and standardization of drug products [131,132]. Unlike conventional manufacturing, 3D printing involves layer-by-layer fabrication and digital design control, requiring updated regulatory frameworks to ensure consistent product quality and patient safety [132,133].
8.1 Quality Assurance and Standardization
Regulatory authorities require that 3D printed pharmaceutical products meet stringent quality standards similar to those of conventionally manufactured drugs [133]. Critical quality attributes (CQAs) such as drug content uniformity, mechanical strength, dissolution profile, and dimensional accuracy must be consistently maintained [134].
Due to variability in printing parameters, robust quality control strategies must be implemented to ensure reproducibility and reliability of the final product [134,135].
8.2 Process Validation and Reproducibility
Process validation is essential to demonstrate that 3D printing systems can consistently produce products meeting predefined specifications [135]. Parameters such as printing temperature, layer thickness, printing speed, and material characteristics must be carefully optimized and validated [136].
The use of Process Analytical Technology (PAT) tools allows real-time monitoring and control of the manufacturing process, improving reproducibility and product quality [136,137].
8.3 Material and Excipient Approval
All materials used in 3D printing, including polymers, excipients, and solvents, must comply with pharmacopeial standards and regulatory requirements [137]. Detailed characterization of materials is necessary to evaluate their compatibility with active pharmaceutical ingredients (APIs), thermal stability, and degradation behavior during the printing process [138].
Regulatory authorities also require toxicological evaluation of new materials used in additive manufacturing [138].
8.4 Stability and Storage Conditions
Stability studies are crucial to assess the impact of 3D printing processes on drug integrity and performance over time [139]. Factors such as exposure to heat, light, and moisture during printing may affect drug stability [139,140].
Stability testing must be conducted according to International Council for Harmonisation (ICH) guidelines to ensure product safety and efficacy throughout its shelf life [140].
8.5 Good Manufacturing Practices (GMP) Compliance
3D printing facilities must comply with Good Manufacturing Practices (GMP) to ensure consistent product quality [141]. This includes proper equipment validation, environmental control, personnel training, and documentation [141,142].
Special considerations are required for decentralized manufacturing settings such as hospital or pharmacy-based 3D printing units [142].
8.6 Regulatory Framework and Approval Pathways
Regulatory frameworks for 3D printed pharmaceuticals are still evolving [143]. Agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have issued preliminary guidance on additive manufacturing [143,144].
However, there is a need for more comprehensive guidelines addressing issues such as complex dosage forms, personalization, and digital design validation [144].
8.7 Digital Design and Data Integrity
Since 3D printing relies on digital design files (e.g., CAD models), ensuring data integrity and cybersecurity is critical [145]. Unauthorized modification of design files could compromise product quality and patient safety [145,146].
Regulatory authorities emphasize the importance of version control, traceability, and secure data management systems [146].
8.8 Personalized Medicine and On-Demand Manufacturing
The concept of personalized medicine and on-demand drug manufacturing presents unique regulatory challenges [147]. Issues such as defining batch size, ensuring quality consistency across individualized products, and assigning responsibility between manufacturers and healthcare providers must be addressed [147,148].
Regulatory frameworks must evolve to accommodate small-scale, patient-specific manufacturing processes [148].
8.9 Post-Marketing Surveillance
Post-marketing surveillance is essential for monitoring the safety and efficacy of 3D printed pharmaceuticals after commercialization [149]. Pharmacovigilance systems must be adapted to capture adverse drug reactions, product defects, and long-term performance data [149,150].
Continuous monitoring ensures early detection of safety issues and supports regulatory decision-making [150].
9. Advantages of 3D Printing in Pharmaceuticals
Three-dimensional (3D) printing offers numerous advantages over conventional pharmaceutical manufacturing methods, making it a promising technology for future drug development [151,152].
9.1 Customization of Dosage Forms
3D printing enables the fabrication of patient-specific dosage forms with tailored drug doses, shapes, and release profiles, supporting personalized medicine [152,153].
9.2 Reduced Material Wastage
Unlike traditional subtractive manufacturing processes, 3D printing is an additive process that minimizes material wastage and improves cost efficiency [153,154].
9.3 Ability to Create Complex Geometries
The technology allows the production of complex structures such as multilayer tablets, hollow systems, and porous matrices that are difficult to achieve using conventional techniques [154,155].
9.4 Improved Patient Compliance
Customized dosage forms, including polypills and orodispersible tablets, reduce pill burden and enhance patient adherence [155,156].
9.5 Rapid Prototyping and Development
3D printing facilitates quick formulation development and testing, reducing time and cost in drug development [156,157].
9.6 On-Demand Drug Manufacturing
10. Limitations and Challenges
Despite its advantages, 3D printing in pharmaceuticals faces several limitations and challenges that must be addressed for widespread adoption [159,160].
10.1 High Initial Cost of Equipment
The cost of 3D printers and associated technologies remains high, limiting accessibility in many healthcare settings [160,161].
10.2 Limited Availability of Pharmaceutical-Grade Materials
There is a limited range of approved polymers and excipients suitable for 3D printing applications [161,162].
10.3 Regulatory Challenges
The lack of well-defined regulatory guidelines for 3D printed pharmaceuticals creates uncertainty in product approval and commercialization [162,163].
10.4 Stability Issues of Drugs During Printing
Exposure to heat (light), or solvents during the printing process may affect the stability of certain drugs, especially thermolabile compounds [163,164].
10.5 Scale-Up and Mass Production Difficulties
3D printing is more suitable for small-batch or personalized production, and scaling up for mass manufacturing remains a significant challenge [164,165].
11. Future Perspectives
Three-dimensional (3D) printing is expected to play a transformative role in the future of pharmaceutical sciences, particularly in the advancement of personalized medicine and innovative drug delivery systems [166,167]. The integration of patient-specific data, including genetic information and disease characteristics, will enable the development of highly individualized therapies with improved efficacy and safety [167,168]. Additionally, the incorporation of artificial intelligence and machine learning is anticipated to enhance formulation design, optimize printing parameters, and predict drug release behavior [168,169].
The development of smart drug delivery systems capable of responding to physiological stimuli such as pH, temperature, and enzymatic activity represents another promising area (169). These systems can provide targeted and controlled drug release, improving therapeutic outcomes [170]. Advancements in 3D bioprinting are expected to revolutionize tissue engineering and regenerative medicine by enabling the fabrication of functional tissues and organs for drug testing and transplantation [170,171]. Furthermore, on-demand drug manufacturing at hospitals and pharmacies may improve drug accessibility and reduce healthcare costs [171,172].
Future progress will depend on the development of novel biocompatible materials, improved printing technologies, and robust regulatory frameworks to ensure safety, efficacy, and quality of 3D printed pharmaceutical products [172,173]. Overcoming challenges related to scalability and cost will be essential for commercialization and widespread adoption [173].
CONCLUSION
3D printing has emerged as a transformative and innovative technology in pharmaceutical sciences, offering a novel approach to drug design and formulation. Its ability to fabricate dosage forms with precise control over drug content, geometry, and release characteristics has significantly advanced the development of patient-centric therapies. The technology enables the production of personalized medicines, polypills, and complex drug delivery systems that are difficult to achieve through conventional manufacturing methods. 3D printing enhances flexibility in formulation development, reduces material wastage, and allows rapid prototyping, thereby accelerating the drug development process. It also holds great promise in improving patient compliance, especially in pediatric and geriatric populations, by enabling customization of dose, shape, and taste.
In conclusion, 3D printing represents a groundbreaking shift toward personalized and precision medicine. With ongoing research and technological improvements, it is poised to revolutionize pharmaceutical manufacturing and play a crucial role in the future of healthcare and drug delivery systems.
REFERENCES
Pragati Patil, Juveriya Patel, Aniket Thanekar, Dhanraj Jadage, A Review on 3D Printing in Drug Design and Advanced Pharmaceutical Formulations, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 4012-4034. https://doi.org/10.5281/zenodo.20229641
10.5281/zenodo.20229641
